Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Mitochondrial and nuclear p53 localization in cardiomyocytes: Redox modulation by doxorubicin (Adriamycin)?

  • Ramaneeya Nithipongvanitch
  • , Wanida Ittarat
  • , Marsha P. Cole
  • , Jitbanjong Tangpong
  • , Daret K. St. Clair
  • , Terry D. Oberley

Producción científica: Review articlerevisión exhaustiva

68 Citas (Scopus)

Resumen

Reactive oxygen (ROS) and nitrogen species (RNS) generation have been proposed to be an important mechanism of doxorubicin (Adriamycin; ADR)-induced cardiotoxicity and cardiomyocyte apoptosis, processes that may be mediated by p53 protein. We note that ADR treatment resulted in increased levels of p53 protein in cardiomyocyte mitochondria and nuclei. Modulation of the cardiomyocyte redox state in genetically engineered mice by modulation of enzymes involved in metabolism of ROS/RNS, manganese superoxide dismutase (MnSOD), or inducible nitric oxide synthase (iNOS), or a combination of these, regulated levels of mitochondrial/nuclear p53 in cardiomyocytes after ADR administration. These observations led to the hypothesis that mitochondrial/nuclear p53 localization and function in the cardiomyocyte response to ADR may be regulated through redox-dependent mechanism(s).

Idioma originalEnglish
Páginas (desde-hasta)1001-1008
Número de páginas8
PublicaciónAntioxidants and Redox Signaling
Volumen9
N.º7
DOI
EstadoPublished - jul 2007

Financiación

FinanciadoresNúmero del financiador
National Childhood Cancer Registry – National Cancer InstituteR01CA094853

    ASJC Scopus subject areas

    • Physiology
    • Biochemistry
    • Molecular Biology
    • Clinical Biochemistry
    • Cell Biology

    Huella

    Profundice en los temas de investigación de 'Mitochondrial and nuclear p53 localization in cardiomyocytes: Redox modulation by doxorubicin (Adriamycin)?'. En conjunto forman una huella única.

    Citar esto